Dalgarno; David C.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Dalgarno; David C..The latest application filed is for "substituted acetylenic pyrazolo[1,5-a]pyridine compounds as kinase inhibitors".
Company Profile
11.31.51
- Dalgarno; David C. - Brookline MA
- DALGARNO; David C. - Cambridge MA
Patent Activity
| Patent | Date |
|---|---|
| Substituted Acetylenic Pyrazolo[1,5-a]pyridine Compounds As Kinase Inhibitors App 20220081440 - Zou; Dong ; et al. | 2022-03-17 |
| Benzimidazole Compounds As C-kit Inhibitors App 20220064144 - BENCIVENGA; Nicholas E. ; et al. | 2022-03-03 |
| Aminothiazole Compounds As C-kit Inhibitors App 20220033392 - Bencivenga; Nicholas E. ; et al. | 2022-02-03 |
| Heteroaryl Compounds For Kinase Inhibition App 20210323976 - Huang; Wei-Sheng ; et al. | 2021-10-21 |
| Benzimidazole compounds as c-Kit inhibitors Grant 11,117,883 - Bencivenga , et al. September 14, 2 | 2021-09-14 |
| Aminothiazole compounds as c-Kit inhibitors Grant 11,001,580 - Bencivenga , et al. May 11, 2 | 2021-05-11 |
| Phosphorous Derivatives As Kinase Inhibitors App 20200317705 - Wang; Yihan ; et al. | 2020-10-08 |
| Bicyclic Heteroaryl Compounds App 20200231588 - Zou; Dong ; et al. | 2020-07-23 |
| Phosphorous Derivatives As Kinase Inhibitors App 20200048288 - Wang; Yihan ; et al. | 2020-02-13 |
| Benzimidazole Compounds As C-kit Inhibitors App 20200039958 - BENCIVENGA; Nicholas E. ; et al. | 2020-02-06 |
| Aminothiazole Compounds As C-kit Inhibitors App 20190352298 - Bencivenga; Nicholas E. ; et al. | 2019-11-21 |
| Heteroaryl Compounds For Kinase Inhibition App 20190218212 - Huang; Wei-Sheng ; et al. | 2019-07-18 |
| Heteroaryl compounds for kinase inhibition Grant 10,227,342 - Huang , et al. | 2019-03-12 |
| Substituted Acetylenic Pyrazolo[1,5-a]pyridine Compounds As Kinase Inhibitors App 20190031656 - Zou; Dong ; et al. | 2019-01-31 |
| Monocyclic Heteroaryl Compounds App 20170369446 - Shakespeare; William C. ; et al. | 2017-12-28 |
| Compounds for inhibiting cell proliferation in EGFR-driven cancers Grant 9,834,571 - Zhu , et al. December 5, 2 | 2017-12-05 |
| Compounds for inhibiting cell proliferation in EGFR-driven cancers Grant 9,834,518 - Dalgarno , et al. December 5, 2 | 2017-12-05 |
| Choline kinase inhibitors Grant 9,834,521 - Zech , et al. December 5, 2 | 2017-12-05 |
| Heteroaryl compounds for kinase inhibition Grant 9,796,712 - Huang , et al. October 24, 2 | 2017-10-24 |
| Phosphorous Derivatives As Kinase Inhibitors App 20170218000 - Wang; Yihan ; et al. | 2017-08-03 |
| Heteroaryl Compounds For Kinase Inhibition App 20170197962 - HUANG; Wei-Sheng ; et al. | 2017-07-13 |
| Heteroaryl Compounds For Kinase Inhibition App 20170166598 - HUANG; Wei-Sheng ; et al. | 2017-06-15 |
| Phosphorous Derivatives as Kinase Inhibitors App 20160376297 - Wang; Yihan ; et al. | 2016-12-29 |
| Bicyclic Heteroaryl Compounds App 20160368917 - Zou; Dong ; et al. | 2016-12-22 |
| Compounds for Inhibiting Cell Proliferation in EGFR-Driven Cancers App 20160244469 - Zhu; Xiaotian ; et al. | 2016-08-25 |
| Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors Grant 9,278,971 - Zou , et al. March 8, 2 | 2016-03-08 |
| Phosphorus derivatives as kinase inhibitors Grant 9,273,077 - Wang , et al. March 1, 2 | 2016-03-01 |
| Novel Choline Kinase Inhibitors App 20160024024 - Zech; Stephan G. ; et al. | 2016-01-28 |
| Phosphorous Derivatives As Kinase Inhibitors App 20150225436 - Wang; Yihan ; et al. | 2015-08-13 |
| Acetylenic heteroaryl compounds Grant 9,090,561 - Wang , et al. July 28, 2 | 2015-07-28 |
| Methods And Compositions For Raf Kinase Mediated Diseases App 20150166591 - Zhu; Xiaotian ; et al. | 2015-06-18 |
| Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors Grant 9,029,533 - Zou , et al. May 12, 2 | 2015-05-12 |
| Phosphorous derivatives as kinase inhibitors Grant 9,012,462 - Wang , et al. April 21, 2 | 2015-04-21 |
| Methods and Compositions for RAF Kinase Mediated Diseases App 20150105377 - Gozgit; Joseph M. ; et al. | 2015-04-16 |
| Azaindole derivatives as kinase inhibitors Grant 8,912,330 - Qi , et al. December 16, 2 | 2014-12-16 |
| Bicyclic Heteroaryl Compounds App 20140288082 - Zou; Dong ; et al. | 2014-09-25 |
| Substituted acetylenic imidazo[1,2-A]pyrazine compounds as kinase inhibitors Grant 8,778,942 - Zou , et al. July 15, 2 | 2014-07-15 |
| Phosphorus Derivatives as Kinase Inhibitors App 20140066406 - Wang; Yihan ; et al. | 2014-03-06 |
| Methods for Inhibiting Cell Proliferation in EGFR-Driven Cancers App 20140024620 - Dalgarno; David C. ; et al. | 2014-01-23 |
| Unsaturated heterocyclic derivatives Grant 8,586,566 - Wang , et al. November 19, 2 | 2013-11-19 |
| Bicyclic Heteroaryl Compounds App 20130231337 - Zou; Dong ; et al. | 2013-09-05 |
| Phosphorus Derivatives as Kinase Inhibitors App 20130225527 - Wang; Yihan ; et al. | 2013-08-29 |
| Phosphorus Derivatives as Kinase Inhibitors App 20130225528 - Wang; Yihan ; et al. | 2013-08-29 |
| Bicyclic Heteroaryl Compounds App 20130196979 - Zou; Dong ; et al. | 2013-08-01 |
| Oral formulations Grant 8,496,967 - Vladyka, Jr. , et al. July 30, 2 | 2013-07-30 |
| Substituted acetylenic imidazo[1,2-A]pyridine compounds as kinase inhibitors Grant 8,470,851 - Zou , et al. June 25, 2 | 2013-06-25 |
| Acetylenic heteroaryl compounds Grant 8,461,167 - Wang , et al. June 11, 2 | 2013-06-11 |
| Acetylenic Heteroaryl Compounds App 20130018046 - Wang; Yihan ; et al. | 2013-01-17 |
| Monocyclic Heteroaryl Compounds App 20130005738 - Shakespeare; William C. ; et al. | 2013-01-03 |
| Compounds for Inhibiting Cell Proliferation in EGFR-Driven Cancers App 20120316135 - Dalgarno; David C. ; et al. | 2012-12-13 |
| Monocyclic Heteroaryl compounds Grant 8,278,307 - Shakespeare , et al. October 2, 2 | 2012-10-02 |
| Phosphorus Derivatives As Kinase Inhibitors App 20120202776 - Wang; Yihan ; et al. | 2012-08-09 |
| Unsaturated Heterocyclic Derivatives App 20120178716 - Wang; Yihan ; et al. | 2012-07-12 |
| Bicyclic Heteroaryl Compounds App 20120135986 - Zou; Dong ; et al. | 2012-05-31 |
| Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors Grant 8,114,874 - Zou , et al. February 14, 2 | 2012-02-14 |
| Unsaturated heterocyclic derivatives Grant 8,071,609 - Wang , et al. December 6, 2 | 2011-12-06 |
| Azaindole Derivatives As Kinase Inhibitors App 20110294806 - Qi; Jiwei ; et al. | 2011-12-01 |
| Oral formulations App 20100247643 - Vladyka, JR.; Ronald S. ; et al. | 2010-09-30 |
| Acetylenic Heteroaryl Compounds App 20090176781 - Wang; Yihan ; et al. | 2009-07-09 |
| Unsaturated Heterocyclic Derivatives App 20090156596 - Wang; Yihan ; et al. | 2009-06-18 |
| Monocyclic Heterocyclic Compounds App 20090149471 - Shakespeare; William C. ; et al. | 2009-06-11 |
| Oral formulations App 20080161335 - Vladyka; Ronald S. ; et al. | 2008-07-03 |
| Bicyclic heteroaryl compounds App 20070191376 - Zou; Dong ; et al. | 2007-08-16 |
| Purine derivatives Grant 7,115,589 - Weigele , et al. October 3, 2 | 2006-10-03 |
| Novel perines App 20050096298 - Metcalf, Chester A. III ; et al. | 2005-05-05 |
| Substituted purine derivatives App 20050065171 - Shakespeare, William C. ; et al. | 2005-03-24 |
| Novel purinse App 20020132819 - Metcalf, Chester A. III ; et al. | 2002-09-19 |
| Novel heterocycles App 20020103161 - Weigele, Manfred ; et al. | 2002-08-01 |
| Proton pump inhibitors Grant 6,420,384 - Weigele , et al. July 16, 2 | 2002-07-16 |
| Purine derivatives App 20020068721 - Weigele, Manfred ; et al. | 2002-06-06 |
| Proton pump inhibitors App 20020010159 - Weigele, Manfred ; et al. | 2002-01-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 